| abstract |
The present invention provides methods relating to novel therapeutic strategies for the treatment of hematological malignancies and inflammatory diseases. In particular, the method comprises formula A Wherein R is H, halo or C1-C6 alkyl; R ′ is C1-C6 alkyl; or a pharmaceutically acceptable salt thereof; and optionally pharmaceutically acceptable Excipients; and optionally administration of one or more additional therapeutic agents selected from the group consisting of bendamustine, rituximab and ofatumumab. |